DK0858323T3 - Fremgangsmåde til fremstilling af implantater indeholdende leuprolid - Google Patents

Fremgangsmåde til fremstilling af implantater indeholdende leuprolid

Info

Publication number
DK0858323T3
DK0858323T3 DK97937521T DK97937521T DK0858323T3 DK 0858323 T3 DK0858323 T3 DK 0858323T3 DK 97937521 T DK97937521 T DK 97937521T DK 97937521 T DK97937521 T DK 97937521T DK 0858323 T3 DK0858323 T3 DK 0858323T3
Authority
DK
Denmark
Prior art keywords
copolymer
mixture
aseptically
peptide
implant
Prior art date
Application number
DK97937521T
Other languages
Danish (da)
English (en)
Inventor
Romano Deghenghi
Original Assignee
Ardana Bioscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26699745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0858323(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ardana Bioscience Ltd filed Critical Ardana Bioscience Ltd
Application granted granted Critical
Publication of DK0858323T3 publication Critical patent/DK0858323T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK97937521T 1996-09-04 1997-07-28 Fremgangsmåde til fremstilling af implantater indeholdende leuprolid DK0858323T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2544496P 1996-09-04 1996-09-04
US08/897,942 US5945128A (en) 1996-09-04 1997-07-21 Process to manufacture implants containing bioactive peptides
PCT/EP1997/004095 WO1998009613A1 (en) 1996-09-04 1997-07-28 Process to manufacture implants containing bioactive peptides

Publications (1)

Publication Number Publication Date
DK0858323T3 true DK0858323T3 (da) 2004-06-28

Family

ID=26699745

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97937521T DK0858323T3 (da) 1996-09-04 1997-07-28 Fremgangsmåde til fremstilling af implantater indeholdende leuprolid

Country Status (14)

Country Link
US (3) US5945128A (es)
EP (1) EP0858323B1 (es)
JP (1) JPH11514678A (es)
KR (1) KR100343645B1 (es)
CN (1) CN1200032A (es)
AT (1) ATE262889T1 (es)
AU (1) AU713123B2 (es)
BR (1) BR9706741A (es)
CA (1) CA2236595A1 (es)
DE (1) DE69728371T2 (es)
DK (1) DK0858323T3 (es)
ES (1) ES2218696T3 (es)
PT (1) PT858323E (es)
WO (1) WO1998009613A1 (es)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
US5362442A (en) 1993-07-22 1994-11-08 2920913 Canada Inc. Method for sterilizing products with gamma radiation
US20040067157A1 (en) * 1993-07-22 2004-04-08 Clearant, Inc. Methods for sterilizing biological materials
EP0788799A3 (en) 1996-02-07 1998-10-21 ASTA Medica Aktiengesellschaft LHRH-Antagonists in the treatment of fertility disorders
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
IT1304152B1 (it) * 1998-12-10 2001-03-08 Mediolanum Farmaceutici Srl Composizioni comprendenti un peptide ed acido polilattico-glicolicoatte alla preparazione di impianti sottocutanei aventi un prolungato
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
WO2000062759A1 (en) * 1999-04-16 2000-10-26 Novo Nordisk A/S Dry, mouldable drug formulation
TW200800298A (en) 2000-01-27 2008-01-01 Zentaris Ag Compressed microparticles for dry injection
US20040086420A1 (en) * 2000-03-23 2004-05-06 Macphee Martin J. Methods for sterilizing serum or plasma
DE60127139T2 (de) * 2000-07-14 2007-12-13 Novo Nordisk A/S Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
US6362308B1 (en) 2000-08-10 2002-03-26 Alkermes Controlled Therapeutics Inc. Ii Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
KR100876538B1 (ko) * 2000-08-17 2008-12-31 아에테르나 젠타리스 게엠베하 Ｌｈｒｈ 길항제의 염의 제조방법
WO2002016557A2 (en) * 2000-08-21 2002-02-28 Rice University Tissue engineering scaffolds promoting matrix protein production
US6682695B2 (en) * 2001-03-23 2004-01-27 Clearant, Inc. Methods for sterilizing biological materials by multiple rates
BR0209914A (pt) * 2001-05-23 2004-04-06 Hexal Ag Produto homogeneizado para implantes e micropartìculas
US6696060B2 (en) * 2001-06-14 2004-02-24 Clearant, Inc. Methods for sterilizing preparations of monoclonal immunoglobulins
CA2451187C (en) 2001-06-22 2012-08-14 Southern Biosystems, Inc. Zero-order prolonged release coaxial implants
US20030031584A1 (en) * 2001-08-10 2003-02-13 Wilson Burgess Methods for sterilizing biological materials using dipeptide stabilizers
US6946098B2 (en) 2001-08-10 2005-09-20 Clearant, Inc. Methods for sterilizing biological materials
US6749851B2 (en) 2001-08-31 2004-06-15 Clearant, Inc. Methods for sterilizing preparations of digestive enzymes
US7252799B2 (en) * 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
GB0122113D0 (en) * 2001-09-11 2001-10-31 Astrazeneca Ab Composition
US20030095890A1 (en) * 2001-09-24 2003-05-22 Shirley Miekka Methods for sterilizing biological materials containing non-aqueous solvents
US6783968B2 (en) 2001-09-24 2004-08-31 Clearant, Inc. Methods for sterilizing preparations of glycosidases
US20030185702A1 (en) * 2002-02-01 2003-10-02 Wilson Burgess Methods for sterilizing tissue
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
US20030124023A1 (en) * 2001-12-21 2003-07-03 Wilson Burgess Method of sterilizing heart valves
US7309468B2 (en) * 2002-05-13 2007-12-18 Becton, Dickinson And Company Protease inhibitor sample collection system
US20040013562A1 (en) * 2002-07-18 2004-01-22 Wilson Burgess Methods for sterilizing milk.
US6908591B2 (en) * 2002-07-18 2005-06-21 Clearant, Inc. Methods for sterilizing biological materials by irradiation over a temperature gradient
CA2501196A1 (en) * 2002-10-10 2004-04-22 Becton, Dickinson And Company Sample collection system with caspase inhibitor
WO2004057959A2 (en) 2002-12-20 2004-07-15 Generipharm, Inc. Intracutaneous injection
GB0304726D0 (en) * 2003-03-01 2003-04-02 Ardana Bioscience Ltd New Process
US9445901B2 (en) * 2003-03-12 2016-09-20 Deger C. Tunc Prosthesis with sustained release analgesic
DE602004026173D1 (de) 2003-04-29 2010-05-06 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
US20040224000A1 (en) * 2003-05-05 2004-11-11 Romano Deghenghi Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
US20050124965A1 (en) * 2003-12-08 2005-06-09 Becton, Dickinson And Company Phosphatase inhibitor sample collection system
US7114074B2 (en) * 2003-12-22 2006-09-26 Graphic Security Systems Corporation Method and system for controlling encoded image production using image signatures
US20060003008A1 (en) 2003-12-30 2006-01-05 Gibson John W Polymeric devices for controlled release of active agents
FR2865938B1 (fr) * 2004-02-05 2006-06-02 Sod Conseils Rech Applic Formulation retard solide comprenant de l'acetate de triptoreline
US20050244478A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Anti-excititoxic sustained release intraocular implants and related methods
US8062652B2 (en) * 2004-06-17 2011-11-22 Endo Pharmaceuticals Solutions Inc. Compositions and methods for treating precocious puberty
WO2006078320A2 (en) 2004-08-04 2006-07-27 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
AU2005304687B2 (en) 2004-11-11 2012-01-19 The General Hosptial Corporation Parathyroid hormone receptor activation and stem and progenitor cell expansion
EP1941799A3 (en) 2004-12-17 2008-09-17 Devgen NV Nematicidal compositions
JP2008525436A (ja) * 2004-12-23 2008-07-17 デュレクト コーポレーション 放出制御組成物
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
AU2006223161B2 (en) * 2005-03-11 2011-05-12 Endo Pharmaceuticals Solutions Inc. Controlled release formulations of octreotide
US7942867B2 (en) * 2005-11-09 2011-05-17 The Invention Science Fund I, Llc Remotely controlled substance delivery device
EP1837014A1 (en) * 2006-03-21 2007-09-26 Hexal Ag Subcutaneous implants containing a degradation-resistant polylactide polymer and a LH-RH analogue
US8206827B2 (en) * 2007-03-15 2012-06-26 Nanovere Technologies, Llc Dendritic polyurethane coating
NZ580803A (en) * 2007-04-27 2012-03-30 Endo Pharmaceuticals Solutions Implant device release agents and methods of using same
MX2009012856A (es) * 2007-06-06 2009-12-15 Debio Rech Pharma Sa Composicion farmaceutica de liberacion lenta hecha de microparticulas.
US20090035351A1 (en) * 2007-07-20 2009-02-05 Medtronic Vascular, Inc. Bioabsorbable Hypotubes for Intravascular Drug Delivery
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
GB0810990D0 (en) * 2008-06-16 2008-07-23 Q Chip Ltd Device and method of making solid beads
JP5536053B2 (ja) * 2008-06-25 2014-07-02 エンド ファーマスーティカルズ ソリューションズ インコーポレイテッド． 離型剤を有するオクトレオチドインプラント
US8071537B2 (en) 2008-06-25 2011-12-06 Endo Pharmaceuticals Solutions Inc. Implantable device for the sustained release of a polypeptide
EP2246063A1 (en) * 2009-04-29 2010-11-03 Ipsen Pharma S.A.S. Sustained release formulations comprising GnRH analogues
JP2013527263A (ja) 2010-03-24 2013-06-27 ビーエーエスエフ ソシエタス・ヨーロピア 熱可塑性ポリエステルの水性分散液の製造方法
US8604101B2 (en) 2010-03-24 2013-12-10 Basf Se Process for producing aqueous dispersions of thermoplastic polyesters
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
EA028572B1 (ru) 2011-03-10 2017-12-29 Ксерис Фармасьютикалс, Инк. Стабильная композиция для парентеральной инъекции и способы ее получения и использования
EP2758594A1 (de) 2011-09-23 2014-07-30 Basf Se Verwendung einer wässrigen dispersion biologisch abbaubarer polyester
DE102011114864A1 (de) 2011-10-05 2013-04-11 Acino Ag Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat
AU2012332556B2 (en) 2011-10-31 2016-05-26 Xeris Pharmaceuticals, Inc. Formulations for the treatment of diabetes
RU2695522C2 (ru) * 2012-05-14 2019-07-23 Тейдзин Лимитед Стерильная композиция
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
DE102013011399A1 (de) 2012-07-31 2014-02-06 Amw Gmbh Implantat mit Risperidon
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
WO2015165821A1 (de) * 2014-04-30 2015-11-05 Acino Supply Ag Verfahren und vorrichtung zur herstellung einer pharmazeutischen zusammensetzung
JP6982495B2 (ja) 2014-08-06 2021-12-17 ゼリス ファーマシューティカルズ インコーポレイテッド ペーストの皮内および／または皮下注射のためのシリンジ、キット、および方法
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
EP4378463A2 (en) 2017-06-02 2024-06-05 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
CH681425A5 (es) * 1990-11-14 1993-03-31 Debio Rech Pharma Sa
US5225205A (en) * 1989-07-28 1993-07-06 Debiopharm S.A. Pharmaceutical composition in the form of microparticles
CH679207A5 (es) * 1989-07-28 1992-01-15 Debiopharm Sa
US5439688A (en) * 1989-07-28 1995-08-08 Debio Recherche Pharmaceutique S.A. Process for preparing a pharmaceutical composition
CH685285A5 (fr) * 1991-12-02 1995-05-31 Debio Rech Pharma Sa Procédé de préparation d'une composition pharmaceutique contenant des sels de peptides.
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US5945128A (en) * 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides

Also Published As

Publication number Publication date
KR20000064317A (ko) 2000-11-06
EP0858323A1 (en) 1998-08-19
ATE262889T1 (de) 2004-04-15
US5945128A (en) 1999-08-31
CA2236595A1 (en) 1998-03-12
BR9706741A (pt) 1999-07-20
DE69728371D1 (de) 2004-05-06
KR100343645B1 (ko) 2002-08-22
US6159490A (en) 2000-12-12
JPH11514678A (ja) 1999-12-14
EP0858323B1 (en) 2004-03-31
WO1998009613A1 (en) 1998-03-12
CN1200032A (zh) 1998-11-25
AU713123B2 (en) 1999-11-25
AU4012197A (en) 1998-03-26
DE69728371T2 (de) 2005-01-13
ES2218696T3 (es) 2004-11-16
PT858323E (pt) 2004-08-31
US6077523A (en) 2000-06-20

Similar Documents

Publication Publication Date Title
DK0858323T3 (da) Fremgangsmåde til fremstilling af implantater indeholdende leuprolid
CA2085750C (en) Osteoinductive pharmaceutical formulations
US5425770A (en) Calcium phosphate/atelopeptide collagen compositions for bone repair
Koempel et al. The effect of recombinant human bone morphogenetic protein‐2 on the integration of porous hydroxyapatite implants with bone
KR102338123B1 (ko) 탄산 수산화인회석을 함유하는 이식가능한 복합체
EP2269663B1 (en) Bone graft and biocomposite
SE434013B (sv) Depa for verksamt emne pa basis av kollagen, ett forfarande for framstellning derav samt anvendning derav
AU2605592A (en) Polymeric compositions useful as controlled release implants
IE902592A1 (en) A method for preparing a sustained-release pharmaceutical peptide composition
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
CN110180027A (zh) 具有改进的操作特征的脱矿质骨基质
CN111511415A (zh) 干式植入物组合物和可注射的水性植入物制剂
DE59706445D1 (de) Verfahren zur herstellung eines implantates, bestehend aus einem resorbierbaren trägermaterial, eine medizinische wirksubstanz wie ein pharmazeutika, antibiotika, cytostatika oder hormon enthaltend
EP2953657B1 (en) Tissue substitute material with biologically active coating
RU2074702C1 (ru) Материал для восстановления костной ткани
DE19529223A1 (de) Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
JPH02212436A (ja) 徐放性基剤
EP3609548B1 (de) Natives knochenersatzmaterial zur förderung der osteogenese, verfahren zu dessen herstellung und verwendungen
MXPA98003452A (es) Proceso para manufacturar implantes que contienen peptidos bioactivos
TH18033B (th) วัสดุที่ฝังติดทางชีวภาพและกรรมวิธีสำหรับการผลิตสิ่งเหล่านี้